लोड हो रहा है...

Risks and benefits of unapproved disease-modifying treatments for neurodegenerative disease

OBJECTIVE: To determine whether patients randomized to unapproved, disease-modifying interventions in neurodegenerative disease trials have better outcomes than patients randomized to placebo by performing a systematic review and meta-analysis of risk and benefit experienced by patients in randomize...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Neurology
मुख्य लेखकों: Feustel, Aden C., MacPherson, Amanda, Fergusson, Dean A., Kieburtz, Karl, Kimmelman, Jonathan
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Lippincott Williams & Wilkins 2020
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7011691/
https://ncbi.nlm.nih.gov/pubmed/31792092
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000008699
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!